A proof-of-concept study with NVDX3, an osteogenic implant of human allogenic origin, in the treatment of low grade degenerative lumbar spondylolisthesis by interbody spine fusion in adults.

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508471-37-00

Enrollment

Registered

2024-01-18

Start date

2023-10-12

Completion date

Unknown

Last updated

2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low grade degenerative lumbar spondylolisthesis by interbody spine fusion

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Luxembourg

None listed

Source: EU CTIS · Data processed: Feb 4, 2026